Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study
By:
Mostafa Javanian, Masomeh Bayani, Mehran Shokri, Mahmoud Sadeghi-Haddad-Zavareh, Arefeh Babazadeh, Babak Yeganeh, Sima Mohseni, Rahele Mehraeen, Mahdi Sepidarkish, Ali Bijani, Ali Rostami, Mehdi Shahbazi, Afrooz Monadi Tabari, Asieh Shabani, Jila Masrour-Roudsari, Amir Hossein Hasanpour, Hossein Emam Gholinejad, Hossein Ghorbani and Soheil Ebrahimpour
References
- 1. ZHOU P, YANG X-L, WANG X-G, HU B, ZHANG L, ZHANG W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579:270–3
- 2. LAI C-C, SHIH T-P, KO W-C, TANG H-J, HSUEH P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Intern J antimicrob agents. 2020; 55:105924.
- 3. ORGANIZATION WH. Coronavirus disease 2019 (COVID-19) : situation report, 71. 2020.
- 4. WU Z, MCGOOGAN JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama. 2020.
- 5. AI T, YANG Z, HOU H, ZHAN C, CHEN C, LV W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642.
- 6. GUO Y-R, CAO Q-D, HONG Z-S, TAN Y-Y, CHEN S-D, JIN H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res. 2020; 7:11.
- 7. LI Y, XIA L. Coronavirus Disease 2019 (COVID-19): Role of chest CT in diagnosis and management. Am J Roentgenol. 2020:1–7.
- 8. CHANG R, SUN W-Z. Repositioning Chloroquine as Ideal Antiviral Prophylactic against COVID-19-Time is Now. Preprints. 2020: 2020030279.
- 9. DHAMA K, SHARUN K, TIWARI R, SIRCAR S, BHAT S, MALIK YS, et al. Coronavirus Disease 2019–COVID-19. Preprints. 2020: 2020030001.
- 10. ADHIKARI SP, MENG S, WU Y-J, MAO Y-P, YE R-X, WANG Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9:1–12.
- 11. HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395:497–506.
- 12. WANG D, HU B, HU C, ZHU F, LIU X, ZHANG J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020; 11:1061–69.
- 13. LI T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2. 0) Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Emerg Microb Infect. 2020; 9:582–5.
- 14. CHEN N, ZHOU M, DONG X, QU J, GONG F, HAN Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395:507–13.
- 15. ZHOU F, YU T, DU R, FAN G, LIU Y, LIU Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395:1054–1062.
- 16. RUAN Q, YANG K, WANG W, JIANG L, SONG J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020:1–3.
- 17. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Intern J Infect Dis. 2020:1–13.
- 18. YANG X, YU Y, XU J, SHU H, LIU H, WU Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020.
- 19. BERMEJO-MARTIN JF, ALMANSA R, MENÉNDEZ R, MENDEZ R, KELVIN DJ, TORRES A. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection: Lymphopenia in severe COVID-19 infection. J Infect. 2020.
- 20. SPROSTON NR, ASHWORTH JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018; 9:754.
- 21. LI J, LI S, CAI Y, LIU Q, LI X, ZENG Z, et al. Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China. medRxiv. 2020.
Language: English
Page range: 161 - 167
Submitted on: Apr 6, 2020
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 Mostafa Javanian, Masomeh Bayani, Mehran Shokri, Mahmoud Sadeghi-Haddad-Zavareh, Arefeh Babazadeh, Babak Yeganeh, Sima Mohseni, Rahele Mehraeen, Mahdi Sepidarkish, Ali Bijani, Ali Rostami, Mehdi Shahbazi, Afrooz Monadi Tabari, Asieh Shabani, Jila Masrour-Roudsari, Amir Hossein Hasanpour, Hossein Emam Gholinejad, Hossein Ghorbani, Soheil Ebrahimpour, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.